Document is current
Any future updates will be listed below
-
Authors
Fontvieille, Emma
Viallon, Vivian
Recalde, Martina
Cordova, Reynalda
Jansana, Anna
Peruchet-Noray, Laia
Lennon, Hannah
Heath, Alicia K.
Aune, Dagfinn
Christakoudi, Sofia
Katzke, Verena
Kaaks, Rudolf
Inan-Eroglu, Elif
Schulze, Matthias B.
Mellemkjær, Lene
Tjønneland, Anne
Overvad, Kim
Farràs, Marta
Petrova, Dafina
Amiano, Pilar
Chirlaque, María-Dolores
Moreno-Iribas, Conchi
Tin Tin, Sandar
Masala, Giovanna
Sieri, Sabina
Ricceri, Fulvio
Panico, Salvatore
May, Anne M.
Monninkhof, Evelyn M.
Weiderpass, Elisabete
Gunter, Marc J.
Ferrari, Pietro
Freisling, Heinz http://orcid.org/0000-0001-8648-4998
-
Funding
Funding for this research was provided by:
World Cancer Research Fund (IIG_2019_1978)
- License Information
-
More Information
Article History
Received: 3 May 2023
Accepted: 16 October 2023
First Online: 23 November 2023
Declarations
:
: All participants from the UK Biobank and the EPIC studies have provided written informed consent to participate in the respective cohorts. UK Biobank has ethical approval from the Northwest Multi-Centre Research Ethics Committee. The EPIC study was approved by the Cancer Ethical Review Committee of IARC and by local ethical committees at the participating centers.The current study was approved by the IARC’s Ethics Committee (No. 23–40).
: Not applicable.
: The authors declare that they have no competing interests.
